Targeting epigenetic regulations in cancer

Area of Science:

• Molecular Biology
• Genetics
• Epigenetics

Background:

• Epigenetic regulation, including DNA methylation and histone modifications, dynamically controls gene expression.
• These regulatory mechanisms are crucial in stem cell biology, development, and tumor genesis.
• Aberrant epigenetic regulation is linked to various diseases, notably cancer.

Purpose of the Study:

• To review key proteins involved in epigenetic regulation via DNA methylation, histone acetylation, and histone methylation.
• To discuss the role of reader proteins that bind to modified histones.
• To explore the association of these epigenetic factors with cancer and recent pharmacological developments.

Main Methods:

• Literature review of studies on epigenetic regulatory proteins.
• Analysis of proteins mediating DNA methylation and histone modifications.
• Examination of reader proteins interacting with modified histones.
• Review of cancer associations and drug development targeting epigenetic proteins.

Main Results:

• Identified key proteins mediating DNA methylation, histone acetylation, and histone methylation.
• Highlighted the function of reader proteins in interpreting epigenetic marks.
• Demonstrated the significant association between epigenetic dysregulation and cancer development.
• Summarized progress in developing drugs targeting epigenetic modifications for cancer therapy.

Conclusions:

• Epigenetic regulation is a complex network involving DNA methylation, histone modifications, and reader proteins.
• Abnormal epigenetic regulation is a hallmark of diseases, particularly cancer.
• Targeting epigenetic mechanisms offers promising therapeutic strategies for cancer and other diseases.